Fluid Management and Tubing in 2026: Precision, Connectivity, and Materials Discipline

Fluid management and tubing have long been treated as foundational elements of medical device design — necessary, heavily specified, and often invisible once integrated into a finished system. That status is changing. In 2026, these components sit at the intersection of several high-value medtech trends: minimally invasive intervention, home-based therapy, smart infusion platforms, singleuse procedure kits, and tighter expectations for sterility, traceability, and sustainability.

For OEMs, the opportunity is no longer limited to supplying tubing, fittings, reservoirs, manifolds, and disposable fluid paths at scale. The market is rewarding suppliers that can help device manufacturers solve system-level problems — flow accuracy, drug compatibility, pressure management, particulate control, leak prevention, usability, and regulatory documentation. In that sense, tubing and fluid management are becoming performance-enabling subsystems rather than passive conduits.

Market Size, Growth, and Outlook

The outlook remains strong across both medical tubing and broader fluid management platforms. Recent market projections place the global medical tubing market at about $12.53 billion in 2025, rising to approximately $18.41 billion by 2030, a compound annual growth rate of 8.0 percent. ¹ The fluid management systems market is projected to grow from roughly $13.26 billion in 2025 to $18.60 billion by 2030, reflecting a CAGR of 7 percent. ²

Those numbers reflect a broadening application base. Tubing is used in catheters and cannulas, drug-delivery systems, bulk disposable tubing, drainage sets, respiratory circuits, dialysis systems, diagnostic instruments, surgical suction/irrigation systems, and laboratory automation. ¹ Fluid management systems, meanwhile, are central to endoscopy, laparoscopy, urology, dialysis, orthopedics, gastroenterology, and other procedure categories where controlled delivery, removal, visualization, or recirculation of fluids affects both workflow and clinical performance. ²

Growth is also tied to where care is occurring. Hospital procedure volumes remain critical, but outpatient sites, ambulatory surgery centers, and home-based therapy are placing new demands on disposables and fluid paths. Products that once could assume trained clinical handling now need to support simpler setup, clearer labeling, reduced connection errors, and predictable performance outside the acute-care environment. ^{3, 4}

From Component to System-Level Design Element

Medical tubing is increasingly engineered around application-specific requirements rather than selected as a generic material format. Designers are balancing flexibility, kink resistance, burst strength, wall thickness, extractables and leachables, sterilization compatibility, bonding performance, transparency, radiopacity, and biocompatibility. In many cases, the tubing must also support increasingly compact device architectures, which creates demand for multi-lumen, co-extruded, braided, reinforced, tapered, and specialty polymer structures. ¹

Fluid management systems are undergoing a similar shift. Rather than functioning as stand-alone hardware, they are being integrated into digital operating rooms, smart pumps, imaging systems, robotic surgical platforms, and procedurespecific disposable kits. For OEMs, this means fluid-path design must account for more than fluid movement. The disposable set may influence pump calibration, alarm performance, occlusion detection, air-in-line monitoring, pressure sensing, and dose accuracy. In connected systems, the tubing set can become part of a validated platform rather than a replaceable commodity. ^{5, 6}

Key Growth Drivers

Minimally invasive surgery remains one of the strongest structural drivers. Procedures that reduce incision size often require more sophisticated insufflation, irrigation, aspiration, visualization, and waste-fluid handling. As procedure volumes expand across urology, gastroenterology, gynecology, orthopedics, and general surgery, fluid management systems must support stable visualization, fast exchange, consistent pressure, and simplified workflow. ²

Chronic disease management is another major force. The continued burden of cancer, diabetes, cardiovascular disease, kidney disease, and other long-term conditions increases demand for infusion therapy, dialysis, drainage, and diagnostic monitoring. The World Health Organization continues to identify noncommunicable diseases as a major cause of mortality worldwide, reinforcing the long-term need for therapies and procedures that rely on reliable fluid delivery and collection. ⁷

Home and alternate-site care are reshaping product requirements. Home infusion, ambulatory pumps, enteral feeding, drainage systems, and remote-care models require components that are not only clinically reliable but also intuitive for patients and caregivers. The National Home Infusion Association has highlighted the role of home infusion in enabling patients to receive therapy outside traditional inpatient settings. ³ As that model expands, OEMs need tubing sets, connectors, clamps, packaging, and instructions that reduce setup complexity and help prevent misconnections or contamination. ^{3, 4}

Fluid Management and Tubing Trends to Watch

Specialty polymers and multi-layer tubing for application-specific performance.
Connected disposables that support pump recognition, traceability, and workflow verification.
Closed-system designs that reduce contamination and handling risk.
Procedure-specific kits for ambulatory surgery and home-care use.
Automated extrusion, bonding, inspection, and leak testing for tighter process control.
Sustainability work focused on material reduction, packaging efficiency, and lifecycle impact.
Regional supply-chain strategies to reduce exposure to resin, sterilization, and logistics disruptions.

Infection prevention remains a defining design priority. CDC guidance on intravascular catheter-related bloodstream infection prevention addresses catheter insertion, maintenance, and infection-control practices across hospital, outpatient, and home healthcare settings. ⁸ For tubing and fluid management suppliers, that translates into continued demand for closed systems, secure connectors, low-dead-space designs, single-use assemblies, and packaging that protects sterility through distribution and point-of-care use. ^{8, 9}

Drug-delivery complexity is also increasing. Biologics, specialty drugs, contrast agents, oncology therapies, and high-value formulations can be sensitive to adsorption, shear, light exposure, particulate contamination, or material incompatibility. Tubing materials and surface properties therefore play a larger role in therapy performance. OEMs are increasingly asking suppliers to provide material data, chemical compatibility information, sterilization validation support, and documentation that helps reduce risk during regulatory review.

Materials and Manufacturing Trends

Material selection is becoming more strategic. PVC remains widely used in many disposable applications, but specialty polymers, thermoplastic elastomers, silicones, fluoropolymers, polyurethanes, polyolefins, and high-performance resins are gaining attention where flexibility, clarity, chemical resistance, low extractables, or sterilization tolerance are required. ¹ This is not simply a substitution story. OEMs are matching materials to specific use cases, cost targets, manufacturing processes, and regional regulatory expectations.

Co-extrusion and multi-layer tubing are especially important where a single material cannot satisfy all performance requirements. A tubing structure may need an inner layer optimized for fluid contact, an intermediate layer for strength or barrier performance, and an outer layer for bonding, handling, or abrasion resistance. Reinforced and braided structures are also valuable where pressure resistance and dimensional stability matter, particularly in pump-driven systems and catheter-based applications.

Manufacturing automation is becoming more important as tubing assemblies grow more complex. Precision extrusion, automated cutting, laser marking, vision inspection, bonding, leak testing, particulate control, and cleanroom assembly all support repeatability. The need for traceability is also increasing as OEMs seek better lot-level control, faster root-cause analysis, and more resilient supply chains.

Connectivity, Sensors, and Smart Fluid Paths

Connected fluid management is emerging in two related ways. First, smart pumps and interoperable systems are increasing the value of disposable components that can be recognized, verified, or calibrated by the capital equipment platform. Second, sensors embedded in or attached to fluid paths can support pressure monitoring, flow confirmation, temperature tracking, bubble detection, and usage data.

Regulatory expectations are important. FDA guidance on interoperable medical devices emphasizes design considerations for devices that exchange and use information safely and effectively. ⁶ For tubing and disposable fluid-path developers, the implication is that connectivity features must be treated as part of the risk-management strategy, not as optional add-ons. Barcode, RFID, NFC, or sensor-enabled disposables may improve workflow and traceability, but they also require careful validation and documentation when they influence clinical use or device performance. ^{5, 6}

Smart fluid paths may be particularly valuable for home care and highrisk infusion applications. A disposable set that confirms correct installation, verifies compatibility with a pump, or flags a pressure anomaly could help reduce errors and improve confidence in decentralized care models. However, these benefits depend on maintaining affordability, usability, and manufacturability.

Market Challenges

Hospitals and alternate-site providers still view many tubing sets and disposable fluid components through a procurement lens. OEMs must therefore show value beyond unit price: reduced procedure time, fewer setup steps, lower infection risk, improved compatibility, fewer recalls, and better inventory control.

Regulatory and quality expectations are also rising. Products that contact fluids, drugs, blood, or tissue may require extensive biocompatibility, chemical characterization, sterilization, shelflife, and performance testing. When tubing becomes part of a connected or pump-controlled system, documentation requirements can extend into interoperability, software-adjacent risk analysis, and human factors. ^{5, 6}

Supply-chain resilience is another concern. The IV fluid shortages experienced in recent years underscored how vulnerable healthcare delivery can be when fluid-related products become constrained. ¹⁰ While tubing and fluid management assemblies are different from saline bags, they share many supply-chain dependencies: resins, sterilization capacity, cleanroom labor, packaging materials, and global logistics. OEMs are responding with dual sourcing, regional manufacturing, supplier qualification programs, and more detailed continuity planning.

Sustainability is becoming harder to ignore. WHO has noted that healthcare activities generate significant waste, including infectious and non-infectious waste streams, while its plastics and health initiative highlights broader concerns around plastic exposure and environmental burden. Single-use fluid paths are often clinically necessary, but manufacturers are under pressure to reduce packaging volume, evaluate recyclable or lower-impact materials where feasible, improve yield, and design products that minimize unnecessary waste without compromising safety. ^{11, 12}

Competitive Landscape and OEM Strategy

Large suppliers retain advantages in scale, regulatory infrastructure, global distribution, and materials expertise. At the same time, specialized OEM and contract manufacturing partners are finding opportunities in advanced extrusion, catheter subassemblies, sterile fluid-path kits, sensor integration, and automated assembly. The most competitive suppliers are those that can move early in the design cycle and help device companies make trade-offs among performance, manufacturability, cost, and compliance.

Customization is becoming more valuable. Procedure-specific kits, preconnected assemblies, color-coded tubing, integrated filters, specialty connectors, and validated pump-set combinations can simplify clinical workflow while differentiating the finished device platform. For smaller suppliers, the path to growth may come from solving hard engineering problems — such as kink resistance in miniaturized devices, low-extractable tubing for sensitive drugs, or reliable bonding between dissimilar materials — rather than competing only on commodity volume.

Product Segmentation and Demand Trends

Demand is strongest where tubing and fluid control directly influence therapy delivery, procedural efficiency, or device safety. Catheters and cannulas, drug-delivery systems, bulk disposable tubing, surgical irrigation and suction sets, dialysis circuits, enteral feeding systems, respiratory tubing, and diagnostic fluidics all remain important application categories. ¹

Hospitals will remain major users, but ambulatory surgery centers and home-care channels are shaping future designs. Products for these settings must be compact, easy to store, clearly labeled, and robust enough to perform under less-controlled conditions. ^{3, 4} This is one reason OEMs are placing more emphasis on packaging, instructions for use, training aids, and human factors alongside traditional material and mechanical specifications.

Strategic Outlook for OEMs

The fluid management and tubing markets are moving toward higher engineering content, deeper platform integration, and stronger documentation expectations. Growth will favor OEMs and suppliers that can combine materials science, clean manufacturing, usability, digital integration, and regulatory discipline.

The most successful companies will not treat tubing as an afterthought. They will design fluid paths as part of the therapeutic system, considering how material choice, connector geometry, pressure behavior, sterility, labeling, traceability, and sustainability affect the total product experience. As care moves into more distributed settings and medical devices become more connected, fluid management will remain a quiet but essential measure of device quality.

For medical device OEMs, the strategic message is to view fluid management and tubing critical interfaces between the device, the therapy, the clinician, and the patient and as essential parts of the connected care ecosystem.